Blog

Agentic AI platform built for government interaction gives policy and legal teams leverage to move faster, stay ahead of the compliance curve, and outmaneuver red tape.

NEW YORK CITY, NY / ACCESS Newswire / July 11, 2025 / Helios, a technology company building the first AI-native operating system for public policy professionals, today announced that it has raised $4 million in seed funding led by Unusual Ventures, with participation from Founders Inc., Alumni Ventures and a select group of strategic angel investors. The company is gaining early traction in a U.S. market with $10B+ in annual software & lobbying spend. It is working to reshape how private entities and government agencies navigate policy and regulatory challenges, with billions already under management by early adopters.

“Policy, compliance, and regulatory affairs professionals shouldn’t be stuck playing defense – constantly reacting to changes they didn’t see coming,” said Joe Scheidler, CEO & Co-Founder. “We built Proxi to change that. In a world where one missed signal can cost millions or derail strategy, Proxi gives public policy and compliance intelligence teams the clarity, speed, and leverage to shape outcomes instead of getting blindsided by them.”

Proxi is the first AI-native OS purpose-built for public policy, regulatory affairs, legal, compliance, and government teams. It replaces the patchwork of tools these professionals rely on to navigate legislative change, manage public-private relationships, and respond to shifting regulatory demands. Whether in the private sector or across federal, state, and local governments – Proxi enables faster, more strategic decision-making in environments where the cost of delay or misalignment is measured in lost contract opportunities, failed policy, or reputational risk. The consequences aren’t just regulatory-they’re existential.

The Proxi platform: (i) delivers instant answers and strategic recommendations based on live federal and subnational legislative and regulatory activity, (ii) drafts memos, filings, and policy documents with built-in editing and team collaboration, (iii) parses long-form bills, reports, and filings into structured insights and risk alerts, (iv) centralizes all relevant policy and regulatory data for team-wide access and historical context, and (v) tracks government relationships, meeting notes, and stakeholder engagement-all in a secure, AI-powered workspace. By integrating these core functions in a single secure system, Proxi replaces manual, fragmented processes with the speed, foresight, and precision modern institutions demand.

Helios’s founding team – Joe Scheidler (CEO), Joseph Farsakh (President), and Brandon Smith (CTO) – brings together experience from the White House, State Department, Microsoft, USAID, Datadog, and King & Spalding, bridging deep public sector insight with world-class technical execution.

“We are excited to back the talented founding team at Helios as they leverage AI to reshape how policy professionals drive critical strategy and growth within their organizations,” said Lars Albright, General Partner at Unusual Ventures. “As regulations continue to evolve rapidly and grow increasingly complex, modern tools that enable enterprises not only to stay informed, but also to respond swiftly and strategically, are more essential than ever.”

More than 100 public policy professionals, including Fortune 500 companies; federal, state, and local regulatory bodies; consultancies; and top lobbying firms have joined Helios’ rapidly growing waitlist. The funding will accelerate product development, team expansion, and go-to-market efforts. To learn more, visit https://heliosintel.ai.

ABOUT HELIOS:

Helios is building the first AI-native operating system for government interaction, empowering public policy, legal, and compliance professionals with end-to-end automation, secure AI agents, and precision tooling. Headquartered in New York City with a presence in Washington, D.C. and California, Helios is on a mission to modernize how institutions engage with government at every level. Learn more at https://heliosintel.ai/.

MEDIA CONTACT: Nina Pfister, MAG PR at nina@mooringadvisorygroup.com.

###

SOURCE: Helios

View the original press release on ACCESS Newswire

– Video webcasts to be available on-demand Tuesday, July 22^nd

– Participating company line-up to be announced 

– “What’s Your Story” Summer Spotlight promo video can be accessed here

FRENCHTOWN, NJ / ACCESS Newswire / July 11, 2025 / JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor “What’s Your Story” Summer Spotlight with on-demand presentations available beginning Tuesday, July 22, 2025.

For the event, management from the participating companies will dive deeper into their dedication to their respective companies, how they got to where they are today and provide insight into why they are so passionate about the products and programs in development.

All investors and interested parties will be able to access the list of participating companies at virtualinvestorco.com. The on-demand presentations will be available on the Virtual Investor website, as well as the Investor sections of the respective company websites.

To access all Virtual Investor events, visit www.virtualinvestorco.com.

JTC Team and Virtual Investor Co. are paid consultants to the participating companies. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies’ websites and the SEC website for the latest information and filings on each company.

About JTC Team

JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on X and LinkedIn.

Contact:

Jenene Thomas
JTC Team, LLC
T: +1 (908) 824-0775
jtc@jtcir.com

SOURCE: JTC Team, LLC

View the original press release on ACCESS Newswire

This third installment of Brenmiller Energy’s (NASDAQ:BNRG) “Viewpoint” Series explores how the Company’s bGen™ system can help unlock the full potential of Small Modular Reactor (SMR) technology. Energy industry veteran and Chief Executive Officer Avi Brenmiller explains how thermal energy storage can bridge the gap between safe, clean heat generation and real-world demand.

TEL AVIV, IL / ACCESS Newswire / July 11, 2025 / For decades, nuclear energy has sat at the center of the clean energy debate. It’s powerful, reliable, carbon-free-and divisive. Critics point to high costs, operational rigidity, and the mismatch between steady-state output and a grid now shaped by real-time demand and fluctuating renewables. But the truth is, the reactor isn’t the problem. It’s what happens after the reactor does its job.

The good news? That problem is solvable. Brenmiller Energy (NASDAQ:BNRG) (the “Company” or “Brenmiller”) – a publicly traded thermal energy storage (TES) company-is one of the few players offering a practical, proven energy storage solution. Its bGen™ system, when modified for SMRs, can act as a thermal buffer, storing clean heat from nuclear reactors and releasing it on demand 24/7/365. It’s potentially an innovative fix to one of nuclear’s biggest limitations – and potentially one of the most important enablers of the nuclear renaissance no one’s talking about yet. But that silence isn’t likely to last.

Why? As governments invest hundreds of millions in Small Modular Reactors (SMRs) and the reactivation of dormant nuclear sites, they’re discovering that critical pieces are missing from the equation: flexibility, dispatchability, and load-following. In short, nuclear needs a buffer-something that can take its powerful, clean, steady heat and make it not only more nimble but usable.

Brenmiller’s bGen™ thermal storage system provides exactly that. And it does so with a simplicity that’s almost deceptive in its power.

The Ally Nuclear Has Always Needed

Let’s start with the obvious: nuclear is great at one thing-baseload. It produces a constant stream of heat and electricity, day and night, rain or shine. But in today’s world, that’s not always an asset.

Modern grids are increasingly volatile, shaped by solar and wind generation that can spike or drop in minutes. Industrial customers need heat when their processes call for it-not necessarily when the reactor happens to be online at full power. And utilities are under pressure to reduce over-generation and improve capacity factor economics without overbuilding.

That’s a tall order for nuclear. But it’s precisely the kind of problem Brenmiller’s TES platform was built to solve.

Our bGen™ system can store thermal energy – whether from a solar field or industrial waste heat – and releases it on demand. It acts like a giant thermal battery, decoupling generation from consumption. If our bGen™ is configured for an SMR, the nuclear reactor can keep humming at its optimal set point while bGen™ could handle the peaks, troughs, and timing mismatches.

And bGen™ isn’t a theoretical solution – it’s commercially proven, already deployed in four countries, and being adapted for the next wave of applications like SMR..

In July 2025, we announced that Brenmiller is developing a new bGen™ configuration specifically engineered for SMRs and high-resilience industrial applications. This product builds on our commercially deployed platform and reflects insights from the installation with Enel, a major European utility company, where bGen™ was used to decarbonize combined heat and power operations.

Unlike conventional nuclear storage integrations, this version of bGen™ requires only minor engineering adjustments. Its high thermal mass, passive heat absorption, built-in heat exchanger, and compatibility with secondary and tertiary nuclear loops make it a natural fit for SMR-linked projects. These features also support decay heat removal, load following, and real-time grid balancing – all essential to meet modern energy expectations.

With the SMR market projected to grow at a 30% CAGR to $72 billion by 2033, we believe our timing and technology positioning are aligned with a global resurgence in nuclear investment, driven by the need for cleaner computing, AI infrastructure, and industrial decarbonization at scale.

Potential Synergies of SMRs and TES

Take Oklo and Nano Nuclear Energy, two emerging leaders in the SMR space. Both are developing compact, next-generation reactors built to deliver reliable, carbon-free energy in decentralized, industrial, and off-grid environments. But even with innovative designs, they face the same limitation: delivering safe clean heat on demand – not just when the reactor produces it.

Brenmiller’s bGen™ system is aiming to cure this shortfall. Following the adaptation of the bGen™ system for SMRs that is under development, we believe that when paired with SMRs, it will enable true demand-driven delivery. The result? Potentially constant generation with flexible dispatch and improved economics. With a TES configured for SMR, capacity factors could stay high and heat could be stored when the market doesn’t need it and sold when prices spike or customers call.

With our development of TES configured for SMR, we aim to ensure that nuclear will be not just clean, but also safe, agile, profitable through Energy-as-a-Service (EaaS) models, and relevant in a world demanding both sustainability and responsiveness.

Safety and Risk Reduction Through Thermal Buffering

Beyond flexibility, TES also improves the safety profile of nuclear systems – a critical factor for regulatory acceptance and public confidence.

The bGen™ system can absorb decay heat – the residual thermal energy that continues after a reactor is shut down. This passive heat removal capability can support safer shutdown procedures and mitigate thermal transients, which can otherwise stress reactor materials and control systems.

TES can also reduce:

• The need for reactor oversizing to meet peak loads

• The risk of load rejection during low-demand periods

• Unnecessary thermal cycling that shortens equipment life

In short, thermal storage could add not just operational value-but structural and safety value.

A Better Business Model for Atomic Energy

Still, we believe that Brenmiller’s value-add doesn’t stop at technical integration – it can impact nuclear’s business case.

By absorbing and time-shifting thermal output, we aim to enable the adapted bGen system to allow nuclear operators to avoid overbuild while serving more customers. Utilities can size SMRs more efficiently and sell heat as a service to nearby industrial clients. Large-scale hydrogen production can operate intermittently without idling reactors. District heating networks gain new reliability and cost stability.

In short, we believe that the adaptation of Brenmiller’s bGen™ system will give nuclear leverage. It’s not just about storing heat – it’s about enabling new revenue streams, de-risking operations, and accelerating return on investment across complex deployments.

And that’s what the sector needs right now. Because nuclear power is no longer just a policy decision. It’s a business. And businesses need flexibility to win.

Clean Heat on Demand

Let’s not forget what’s at stake here.

Industrial heat accounts for more than 25% of global final energy consumption. And most of it still comes from fossil fuels. While electricity is going green fast, thermal energy has lagged behind – not because we lack clean sources, but because we lack the systems to make clean heat dispatchable.

This is the bottleneck. And we believe that Brenmiller’s TES tech is one of the very few solutions on the market that’s modular, commercially ready, and fuel-agnostic.

That last part matters. Because while today’s conversation may be about nuclear, Brenmiller’s bGen™ is currently being deployed as a solution for electrification of industrial heat from different sources. That means it’s not just a bolt-on – it’s infrastructure. And for any clean heat strategy to succeed, infrastructure wins the day.

Action Over Debate and Academia

The nuclear sector doesn’t need another whitepaper or pilot-it needs tools that work today.

Our systems are already operational, with global collaborations in energy and industry. And with the current development of our new bGen™ configuration for SMRs, we’re aiming to deliver a technology designed to support clean baseload generation with the responsiveness that today’s grid and industrial customers demand.

While others remain in R&D, we are actively shaping the energy infrastructure of tomorrow through modifications to our existing bGen platform. If nuclear is going to thrive – not just survive – it will need TES solutions as a key ally. We believe that bringing TES into the nuclear conversation could be what finally proves the skeptics wrong about the most powerful energy source on Earth.

By Avi Brenmiller, Chief Executive Officer, Brenmiller Energy Ltd., a global provider of thermal energy storage solutions deployed across Europe, Israel, and the U.S.

About bGen™

bGen™ ZERO is Brenmiller’s TES system, which converts electricity into heat to power sustainable industrial processes at a price that is competitive with natural gas. The bGen™ ZERO charges by capturing low-cost electricity from renewables or the grid and stores it in crushed rocks. It then discharges steam, hot water, or hot air on demand according to customer requirements. The bGen™ ZERO also supports the development of utility-scale renewables by providing critical flexibility and grid-balancing capabilities. bGen™ ZERO was named among TIME’s Best Inventions of 2023 in the Green Energy category and won Gold in the Energy Storage and Management category at the 2025 Edison Awards.

About Brenmiller Energy Ltd.

Brenmiller Energy helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller’s patented bGen™ ZERO thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. It charges using low-cost renewable electricity and discharges a continuous supply of heat on demand and according to its customers’ needs. The most experienced thermal battery developer on the market, Brenmiller operates the world’s only gigafactory for thermal battery production and is trusted by leading multinational energy companies. For more information visit the Company’s website at https://bren-energy.com/ and follow the company on X and LinkedIn.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the company is using forward-looking statements in this press release when it discusses: the Company’s belief that its bGen™ system can help unlock the full potential of SMR technology; that the Company expects that nuclear energy’s limitations can be solved with its bGen™ thermal buffer system; that the Company anticipates increasing interest in its solution as governments invest in SMRs and nuclear site reactivations; that the bGen™ system will be able to provide flexibility, dispatchability, and load-following needed for modern nuclear applications; the Company’s belief that bGen™ is a match for addressing timing mismatches and peak demands in energy use; the future adaptation of the bGen™ for SMR applications and its future advantages; future SMR market growth estimations; that bGen™ will be able to improve the safety profile of nuclear systems by passively absorbing decay heat; and that the adapted bGen™ system can enable new revenue streams, de-risk operations, and accelerate ROI. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain crucial factors may affect the company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company’s results include, but are not limited to: the company’s planned level of revenues and capital expenditures; risks associated with the adequacy of existing cash resources; the demand for and market acceptance of our products; impact of competitive products and prices; product development, commercialization or technological difficulties; the success or failure of negotiations; trade, legal, social and economic risks; and political, economic and military instability in the Middle East, specifically in Israel. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the company, including those set forth in the Risk Factors section of the company’s Annual Report on Form 20-F for the year ended December 31, 2024 filed with the SEC on March 4, 2025, which is available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact:

investors@bren-energy.com

SOURCE: Brenmiller Energy

View the original press release on ACCESS Newswire

ORLANDO, FL / ACCESS Newswire / July 11, 2025 / RedChip Companies will air interviews with Brag House Holdings, Inc. (NASDAQ:TBH) and FibroBiologics, Inc. (NASDAQ:FBLG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, July 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Access the interviews in their entirety at:

• TBH:https://www.redchip.com/assets/access/tbh_access

• FBLG: https://www.redchip.com/assets/access/fblg_access

In an exclusive interview, Lavell Juan Malloy II, CEO and Co-Founder of Brag House, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how Brag House is redefining brand engagement for Gen Z through its social gaming and data-driven platform. Malloy highlights the Company’s unique ability to connect brands with the highly sought-after Gen Z demographic by fusing college sports rivalries, casual gaming, and community-based interaction into a seamless digital experience. With proven success through partnerships with Coca-Cola, McDonald’s, the Denver Broncos, and Learfield, Brag House delivers industry-leading engagement metrics-including CPC and CPM rates significantly below industry averages. Malloy also outlines the Company’s strategic alliance with Learfield, powering Brag’s national expansion across over 200+ universities, and shares insights into Brag’s multi-tiered monetization model and scalable B2B data solutions-positioning the Company at the convergence of three massive markets: gaming, advertising, and analytics.

Pete O’Heeron, CEO of FibroBiologics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to spotlight the company’s pioneering work in fibroblast-based cell therapies. O’Heeron discusses the advantages of fibroblasts over traditional stem cells, highlighting their regenerative and immunomodulatory properties, scalability, and safety profile. He outlines the Company’s robust pipeline, led by CYWC628 for diabetic foot ulcers, which is slated to enter a Phase 1/2 clinical trial in Australia later this year. Additional programs, including CybroCell™ for degenerative disc disease and CYMS101 for multiple sclerosis, target multi-billion-dollar markets and are supported by promising preclinical and early human data. With over 240 issued and pending patents, a recently completed cGMP-compliant cell bank, and a seasoned leadership team, FibroBiologics is advancing a scalable, off-the-shelf platform poised to transform treatment for chronic diseases and deliver significant long-term value to shareholders.

TBH and FBLG are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

About Brag House

Brag House is a leading media technology gaming platform dedicated to transforming casual college gaming into a vibrant, community-driven experience. By seamlessly merging gaming, social interaction, and cutting-edge technology, the Company provides an inclusive and engaging environment for casual gamers while enabling brands to authentically connect with the influential Gen Z demographic. For more information, visit www.braghouse.com.

About FibroBiologics

Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit www.FibroBiologics.com.

About RedChip Companies

RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

To learn more about RedChip’s products and services, please visit:

https://www.redchip.com/corporate/investor_relations

“Discovering Tomorrow’s Blue Chips Today”™

Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

Follow RedChip on Twitter: https://twitter.com/RedChip

Follow RedChip on YouTube: https://www.youtube.com/@redchip

Follow RedChip on Rumble: https://rumble.com/c/c-3068340

Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com

SOURCE: RedChip Companies, Inc.

View the original press release on ACCESS Newswire

ONTARIO, CA / ACCESS Newswire / July 11, 2025 / Focus Universal Inc. (NASDAQ:FCUV) (“Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT), 5G and SEC Financial Reporting AI-Driven Automation Software, is pleased to announce today that it has signed a contract with Shenzhen Donghui Precision Mold Manufacturing Co., Ltd. and officially commenced the mold tooling design for the Universal Smart Internet of Things (IoT) today. This marks a pivotal milestone in the commercialization of the Universal Smart IoT, a breakthrough that has been over two decades in the making.

Although IoT has long been recognized as a revolutionary technology with the potential to change the world-consistently ranking as the #1 transformative technology, however widespread adoption has been limited by high development costs and technical complexity. Focus Universal has dedicated over 20 years to researching and overcoming these barriers. The Universal Smart IoT, an innovative platform that radically simplifies IoT development and reduces its associated costs.

Unlike traditional IoT systems, where engineers continually start from scratch, Focus’ platform provides a 90% pre-built foundation. Different IoT devices can now share 90% of the same hardware and software, substantially reducing development costs and complexity. This unique approach not only accelerates time-to-market but also democratizes access to IoT solutions.

Further enhancing this ecosystem is Focus Universal’s Universal Smart Software Platform, which eliminates the need for multiple device-specific applications. Engineers no longer need to build separate apps for every IoT product-Focus’ platform supports them all without sacrificing performance or functionality. This streamlined app development process significantly cuts costs and improves efficiency, allowing Focus to offer the IoT platform to customers at a fraction of the cost required to develop custom solutions.

One of Focus’ most revolutionary products, the Ubiquitor, exemplifies this efficiency. It is capable of connecting to any sensor-inclusive of a large number of independent sensors-without theoretical limits. As more sensors are added, the average cost of the Ubiquitor per sensor becomes negligible. This results in an effective cost that approaches that of the sensors alone-already significantly lower than traditional devices. When used in conjunction with the universal platform, the total development cost is a fraction of conventional approaches, offering substantial savings in both raw materials and engineering time.

This milestone signals a new era for the Internet of Things. After two decades of innovation, we are now ready to move forward with full-scale production and commercialization. In doing so, we not only fulfill the promise to shareholders but also demonstrate to the world that deploying complex IoT technology can be as easy as plugging in an office phone. The platform provides both a competitive edge and cost savings even when compared to traditional, non-IoT devices-thanks to universal hardware and software shared across all sensors. Switching from one sensor to another requires no change to the underlying device’s hardware or software, enabling true interoperability across devices.

The IoT market was valued at $0.54 trillion in 2022 and is projected to grow to $3.30 trillion by 2030, with a CAGR of 26.1%. Yet despite its promise, industry surveys reveal that a majority of IoT projects fail-Cisco reported a 75% failure rate, and Microsoft found that 30% of IoT projects fail at the proof-of-concept stage. Focus Universal’s Universal Smart IoT technology was specifically developed to overcome these challenges and unlock the full potential of the IoT revolution.

About Focus Universal:
Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and eight trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets.

Forward-Looking Statements:
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof and Focus Universal specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise.

For company inquiries, please contact:
Investor Relations
626-272-3883
ir@focusuniversal.com

SOURCE: Focus Universal Inc.

View the original press release on ACCESS Newswire

MCLEAN, VA / ACCESS Newswire / July 11, 2025 / Gladstone Land Corporation (Nasdaq:LAND) (“Gladstone Land” or the “Company”) announced that its board of directors has authorized a share repurchase program for up to $20,000,000 of the Company’s 6.00% Series B Cumulative Redeemable Preferred Stock (Nasdaq: LANDO) and up to $35,000,000 of the Company’s 6.00% Series C Cumulative Redeemable Preferred Stock (Nasdaq: LANDP) (together, the “Preferred Stock Repurchase Program”). The repurchases are intended to be implemented through open market transactions on U.S. exchanges or in privately negotiated transactions, in accordance with applicable securities laws, and any market purchases will be made during applicable trading window periods or pursuant to any applicable Rule 10b5-1 trading plans. The timing, prices, and sizes of repurchases will depend upon prevailing market prices, general economic and market conditions and other considerations. The board’s authorization of the Preferred Stock Repurchase Program expires July 10, 2026, and the Preferred Stock Repurchase Program may be suspended or discontinued at any time and does not obligate the Company to acquire any particular amount of preferred stock.

“After a thorough analysis and in consultation with our board of directors, we are announcing another share repurchase authorization as part of a capital allocation strategy that we believe is in the best interest of our shareholders and our business. We believe that the current market conditions provide an attractive buying opportunity for our preferred stock and that using capital to repurchase our preferred shares at appropriate prices represents a favorable strategic use of capital,” said David Gladstone, President of the Company.

About Gladstone Land Corporation:

Founded in 1997, Gladstone Land is a publicly traded real estate investment trust that acquires and owns farmland and farm-related properties located in major agricultural markets in the U.S. The Company currently owns 150 farms, comprised of approximately 103,000 acres in 15 different states and over 55,000 acre-feet of water assets in California. Gladstone Land’s farms are predominantly located in regions where its tenants are able to grow fresh produce annual row crops, such as berries and vegetables, which are generally planted and harvested annually. The Company also owns farms growing permanent crops, such as almonds, blueberries, figs, olives, pistachios, and wine grapes, which are generally planted every 20-plus years and harvested annually. Over 30% of the Company’s fresh produce acreage is either organic or in transition to become organic, and nearly 20% of its permanent crop acreage falls into this category. The Company may also acquire property related to farming, such as cooling facilities, processing buildings, packaging facilities, and distribution centers. Gladstone Land pays monthly distributions to its stockholders and has paid 149 consecutive monthly cash distributions on its common stock since its initial public offering in January 2013. The current per-share distribution on its common stock is $0.0467 per month, or $0.5604 per year. Additional information, including detailed information about each of the Company’s farms, can be found at www.GladstoneLand.com.

Owners or brokers who have farmland for sale in the U.S. should contact:

• Western U.S. – Bill Reiman at (805) 263-4778 or Bill.R@GladstoneLand.com;

• Mid-Atlantic and Midwest U.S. – Joey Van Wingerden at (703) 287-5914 or Joe.V@GladstoneLand.com; or

• Southeastern U.S.- Brett Smith at (703) 287-5837 or Brett.S@GladstoneLand.com.

Lenders who are interested in providing Gladstone Land with long-term financing on farmland should contact Jay Beckhorn at (703) 587-5823 or Jay.Beckhorn@GladstoneCompanies.com.

For stockholder information on Gladstone Land, call (703) 287-5893. For Investor Relations inquiries related to any of the monthly dividend-paying Gladstone funds, please visit www.GladstoneCompanies.com.

CAUTION CONCERNING FORWARD-LOOKING STATEMENTS:

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements inherently involve certain risks and uncertainties, although they are based on the Company’s current plans that are believed to be reasonable as of the date of this press release. Factors that may cause actual results to differ materially from these forward-looking statements include, but are not limited to, the Company’s ability to procure financing for investments, downturns in the current economic environment, the performance of its tenants, the impact of competition on its efforts to renew existing leases or re-lease real property, and significant changes in interest rates. Additional factors that could cause actual results to differ materially from those stated or implied by its forward-looking statements are disclosed under the caption “Risk Factors” within the Company’s Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC on February 19, 2025, and certain other documents filed with the SEC from time to time. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

For further information: Gladstone Land, (703) 287-5893

SOURCE: Gladstone Land Corporation

View the original press release on ACCESS Newswire

Clear Start Tax shows married couples how to avoid costly filing mistakes and save more when back taxes are involved.

IRVINE, CA / ACCESS Newswire / July 11, 2025 / Married taxpayers dealing with back taxes are often surprised to learn that filing separately to “protect” one spouse from IRS collections can actually lead to higher tax bills, lost credits, and fewer resolution options. According to Clear Start Tax, understanding the pros and cons of married filing jointly vs. separately is critical for couples hoping to resolve tax debt while preserving as much income as possible.

“Filing separately might feel safer when one spouse has IRS issues – but it usually ends up being more expensive,” said the Head of Client Solutions at Clear Start Tax. “In many cases, joint filing opens the door to relief programs, better deductions, and faster resolution.”

Why Filing Separately Can Backfire for Couples With Tax Debt

Some couples assume that filing separately shields one spouse’s income or refunds from being seized. While separate filing may delay IRS collection on a refund, it doesn’t always protect shared income or assets, especially in community property states. And in many cases, filing separately ultimately results in:

• Higher overall tax liability

• Loss of key deductions and credits (like the Earned Income Credit or Child Tax Credit)

• Reduced access to Fresh Start benefits or less favorable Offer in Compromise terms

• Longer resolution timelines and more paperwork

How Filing Together Could Be the Smartest Move for Tax Relief

Even when one spouse owes back taxes, joint filing can result in lower taxes and greater access to IRS relief programs. Clear Start Tax helps couples explore the advantages of working together, not separately.

• Qualify for a lower combined tax rate

• Maintain access to credits that reduce their liability

• Negotiate as a unit for an Offer in Compromise or installment plans

• Streamline the resolution process with one case file

For situations where only one spouse is responsible for the debt, programs like Innocent Spouse Relief or Injured Spouse Allocation may protect the non-liable spouse, without sacrificing the benefits of joint filing.

“The IRS gives couples a way to protect the innocent spouse while still getting the best outcome,” said the Head of Client Solutions. “We help clients understand their rights and design a strategy that keeps more money in their household.”

The Fresh Start Program Can Help Couples Settle Tax Debt Together

This IRS initiative allows struggling taxpayers – including married couples – to settle or restructure their tax debt based on what they can reasonably afford. Clear Start Tax walks couples through every step of the process.

• Settlements for less than the full amount owed

• Reduced penalties and halted interest

• Affordable payment plans based on household income

By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

Joint Returns Come With Risk – But Also With Options

While joint returns mean both spouses are legally responsible for the full tax bill, Clear Start Tax helps clients explore:

• Partial-pay agreements

• Spousal relief requests

• Asset protection strategies

• Custom IRS settlement negotiations

These strategies can balance legal responsibility while still maximizing the couple’s chances of saving money and moving forward.

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/
(888) 710-3533

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB1-targeting drugs

MIAMI, FL / ACCESS Newswire / July 11, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) today announced new preclinical results from SKNY-1, an oral drug candidate for obesity and nicotine addiction currently under definitive agreement for acquisition. In a validated behavioral model used to measure Cannabinoid 1 receptor (CB1) related anxiety-like effects, SKNY-1 demonstrated clear reversal of anxiety-related behavior induced by a CB1 activator, setting it apart from earlier CB1-targeting drugs that were discontinued due to serious central nervous system (CNS) effects.

SKNY-1 is being developed as a potential oral treatment for obesity and addiction. It has previously been shown to achieve up to 30% weight loss, reverse high-calorie food and nicotine cravings, and preserve muscle mass in preclinical models. These new findings suggest that SKNY-1 may deliver these therapeutic effects without emotional or behavioral disruption, an important factor in long-term treatment adherence.

“These findings are a significant step forward,” said Erez Aminov, Chief Executive Officer of MIRA. “The ability to suppress appetite and cravings while reversing anxiety-like effects is critical. These results reinforce the differentiated approach behind SKNY-1 and its potential role as a novel oral treatment in large, underserved markets.”

About the Study

The study used the light-dark preference test in zebrafish-a validated behavioral model to assess anxiety-related responses. Zebrafish naturally prefer darker environments due to an innate fear of predators. However, when anxiety levels are elevated, they avoid the light even more strongly spending more time in the dark. Reduced dark preference (i.e., more time in the light) is interpreted as a calming effect.

Four groups were evaluated:

• Control Group (No Drug): Fish showed balanced behavior between light and dark environments.

• CP55,940 Group (CB1 Agonist): These animals spent significantly more time in the dark, confirming that CB1 activation increases anxiety at higher doses. Interestingly, at lower doses, CP55,940 produced a calming effect-reducing dark preference and encouraging exploration of the light area.

• Rimonabant Group (CB1 Inverse Agonist): Fish treated with Rimonabant also showed increased dark-zone time and exhibited a greater increase in anxiety-like behavior than the CB1 agonist group, under both high and low doses of agonist-consistent with the known psychiatric effects that led to Rimonabant’s market withdrawal.

• SKNY-1 Groups: In animals co-treated with CP55,940, SKNY-1 significantly reversed the anxiety-inducing effects of high-dose CP55,940 and enhanced the calming effects at low doses. In all conditions, SKNY-1 brought anxiety-like behavior back to control or better-than-control levels.

These results suggest SKNY-1 may help stabilize mood and stress-related behavior-a potential advantage in treating both metabolic and addictive disorders.

A New Approach to Endocannabinoid Modulation

SKNY-1 targets the endocannabinoid system (ECS)-a key regulator of hunger, emotion, reward, and addictive behavior-through a multi-pathway approach:

• Biased CB1 antagonism blocks β-arrestin signaling (linked to cravings and compulsive behavior) while preserving G-protein signaling (important for emotional regulation).

• CB2 partial agonism may reduce inflammation in the brain, which is increasingly recognized as a driver of anxiety, depression, and cognitive decline. By lowering neuroinflammation, SKNY-1 may help preserve emotional balance and support cognitive resilience.

• Mild inhibition of MAO-B regulates dopamine, which plays a role in motivation and behavioral control.

• No inhibition of MAO-A confirmed through in vitro screening-important because MAO-A inhibitors are associated with mood instability, drug interactions, and safety concerns.

This multi-target profile gives SKNY-1 a differentiated mechanism that may allow it to reduce cravings and weight while supporting emotional health-without the psychiatric side effects that limited earlier CB1 or MAO-based drugs.

“The ability to block cravings while preserving emotional balance is a key challenge in this field,” said Dr. Itzchak Angel, MIRA’s Chief Scientific Advisor. “SKNY-1 appears to meet that challenge head-on. The demonstration that its profile is significantly different than rimonabant in its interaction with CB1 agonists, reinforces the unique pharmacological profile of the drug.”

Market Opportunity

Obesity and addiction are among the most urgent and expensive public health challenges globally. In the U.S. alone, the economic burden of obesity and related chronic diseases is estimated at $1.7 trillion annually, equivalent to over 9% of the nation’s GDP (Milken Institute, 2023). Yet despite significant commercial investment, current therapies remain limited by efficacy gaps and tolerability challenges.

Current GLP‑1 therapies like semaglutide deliver weight loss but are injectables, often cause gastrointestinal side effects, and can result in loss of lean muscle mass. Smoking cessation therapies such as varenicline or bupropion offer modest long-term success and may carry psychiatric warnings that restrict their use in sensitive patient populations. Earlier CB1-targeting drugs, including rimonabant, were withdrawn due to severe mood disorders. Furthermore, broad MAO inhibition-especially MAO‑A-has long been associated with mood instability and dangerous food-drug interactions.

SKNY‑1 was developed to address those limitations directly. With oral administration, differentiated pharmacology, and potential dual efficacy in obesity and nicotine addiction, SKNY‑1 may offer a best-in-class profile. Its lack of MAO‑A inhibition, confirmed in vitro, further enhances its therapeutic promise.

Next Steps

MIRA is currently preparing for shareholder approval related to the proposed acquisition of SKNY Pharmaceuticals, Inc. Pending approval, the Company expects to initiate Investigational New Drug (IND)-enabling studies for SKNY-1 as a next step toward human clinical trials.

About MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company’s pipeline includes oral drug candidates designed to address significant unmet medical needs in areas such as neuropathic pain, inflammatory pain, obesity, addiction, anxiety, and cognitive decline.

Cautionary Note Regarding Forward-Looking Statements

This press release and the statements of MIRA’s management related thereto contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any statements in this press release that are not historical facts may be deemed forward-looking. Any forward-looking statements in this press release are based on MIRA’s current expectations, estimates, and projections only as of the date of this release and are subject to a number of risks and uncertainties (many of which are beyond MIRA’s control) that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including related to MIRA’s potential merger with SKNY Pharmaceuticals, Inc. These and other risks concerning MIRA’s programs and operations are described in additional detail in the Annual Report on Form 10-K for the year ended December 31, 2024, and the Form 14A filed by MIRA on June 18, 2025, and other SEC filings, which are on file with the SEC at www.sec.gov and on MIRA’s website at https://www.mirapharmaceuticals.com/investors/sec-filings. MIRA explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Contact:
Helga Moya
info@mirapharma.com
(786) 432-9792

SOURCE: MIRA Pharmaceuticals

View the original press release on ACCESS Newswire

TORONTO, ON / ACCESS Newswire / July 11, 2025 / Northern Superior Resources Inc. (“Northern Superior” or the “Company“) (TSXV:SUP)(OTCQB:NSUPF)(GR:D9M1) is pleased to announce that, in furtherance to a binding term sheet that was announced on June 16, 2025, it has entered into an asset purchase agreement with TomaGold Corporation for the acquisition of the Hazeur, Monster Lake East, and Monster Lake West Properties (the “Transaction“). Additional information regarding the Transaction and the properties is available in the initial announcement.

The Company anticipates the Transaction to close as early as next week.

About Northern Superior Resources Inc.

Northern Superior is a gold exploration company focused on the Chibougamau Camp in Québec, Canada. The Company has consolidated the largest land package in the region, with total land holdings currently exceeding 62,000 hectares. The main properties include Philibert, Lac Surprise, Chevrier, and Croteau. Northern Superior also owns 56% of ONGold Resources Ltd. (TSXV:ONAU) (OTCQX:ONGRF) which is advancing promising exploration assets in Northern Ontario and Manitoba, including the district-scale TPK Project and Monument Bay. Agnico Eagle Mines Limited owns 15% of ONGold Resources Ltd.

The Philibert Project is located 9 km from IAMGOLD Corporation’s Nelligan¹ Gold project. Philibert hosts a maiden 43-101 inferred resource of 48.5 M tonnes at 1.10 g/t Au for 1,708,800 ounces Au and an indicated resource of 7.9 M tonnes at 1.10 g/t Au for 278,900 ounces Au.² Northern Superior holds a majority stake of 75% in the Philibert Project, with the remaining 25% owned by SOQUEM, and retains an option to acquire the full 100% ownership of the project. Chevrier hosts an inferred mineral resource of 15.7 M tonnes at 1.29 g/t Au for 652,000 ounces Au (underground and open pit) and an indicated mineral resource of 6.4 M tonnes at 1.26 g/t Au for 260,000 ounces Au.³ Croteau hosts an inferred mineral resource of 11.6 M tonnes at 1.7 g/t Au for 640,000 ounces Au.⁴ Lac Surprise hosts the Falcon Zone Discovery, interpreted to be the western strike extension of IAMGOLD Corporation’s Nelligan Gold project.

Northern Superior is a reporting issuer in British Columbia, Alberta, Ontario and Québec, and trades on the TSX-V under the symbol SUP and the OTCQB Venture Market under the symbol NSUPF. For further information, please refer to the Company’s website at www.nsuperior.com or the Company’s profile on SEDAR+ at www.sedarplus.ca.

Qualified Person (“QP”)

The technical content and drilling results contained in this news release have been prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101“) and have been reviewed and approved by Ms. Melanie Pichon, P.Geo., Senior Geologist for Northern Superior. Ms. Pichon is a QP under the NI 43-101 and is not considered independent.

Northern Superior Resources Inc. on Behalf of the Board of Directors

Simon Marcotte, CFA, President and Chief Executive Officer

Contact Information
Katrina Damouni
Director – Corporate Development
Tel: +44 7795 128583 (Mobile/WhatsApp)
info@nsuperior.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of the applicable Canadian securities legislation that is based on expectations, estimates, projections and interpretations as at the date of this news release. The information in this news release about the Transaction, the timing of the Transaction and any other information herein that is not a historical fact may be “forward-looking information”. Any statement that involves discussions with respect to predictions, expectations, interpretations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “interpreted”, “management’s view”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward- looking information and are intended to identify forward-looking information. This forward-looking information is based on reasonable assumptions and estimates of management of Northern Superior, at the time it was made, involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the companies to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Although the forward-looking information contained in this news release is based upon what management believes, or believed at the time, to be reasonable assumptions, the parties cannot assure shareholders and prospective purchasers of securities that actual results will be consistent with such forward-looking information, as there may be other factors that cause results not to be as anticipated, estimated or intended, and neither party nor any other person assumes responsibility for the accuracy and completeness of any such forward-looking information. Neither party undertakes, and assumes no obligation, to update or revise any such forward-looking statements or forward-looking information contained herein to reflect new events or circumstances, except as may be required by law.

¹ “lAMGOLD Announces Significant Increase in Nelligan Ounces & Update of Global Mineral Reserves and Resources”;

IAMGOLD reports increase in mineral reserves and resources at existing assets, with increase in resources at Gosselin; IAMGOLD Corporation News Release dated February 15, 2024, October 23, 2024, and February 20, 2025. Note that the technical and scientific information disclosed from neighboring properties does not apply to any other properties of the area.

² Independent Technical Report MINERAL RESOURCES ESTIMATION OF THE PHILIBERT PROJECT Québec, Canada. September 22, 2023. Prepared in accordance with NI 43-101 by Goldminds Geoservice Inc. to Northern Superior Resources. Philibert hosts a maiden 43-101 inferred resource of 48.5 Mt at 1.10 g/t Au for 1,708,800 ounces Au and an indicated resource of 7.9 Mt tonnes at 1.10 g/t Au for 278,900 ounces Au Note that the technical and scientific information disclosed from neighboring properties does not apply to any other properties of the area.

³ NI 43-101 Technical Report Mineral Resource Estimation for the Chevrier Main Deposit, Chevrier Project Chibougamau, Quebec, Canada, October 20, 2021, Prepared in accordance with NI 43-101 by Lions Gate Geological Consulting Inc. IOS Services Géoscientifiques Inc. for Northern Superior. Chevrier hosts an inferred mineral resource of 15.7 Mt at 1.29 g/t Au for 652,000 ounces Au (underground and open pit) and an indicated mineral resource of 6.4 Mt at 1.26 g/t Au for 260,000 ounces Au Note that the technical and scientific information disclosed from neighboring properties does not apply to any other properties of the area.

⁴ Chalice Gold Mines Limited and Northern Superior Resources Inc. Technical Report on the Croteau Est Gold Project, Québec, September 2015, Prepared in accordance with NI 43-101 by Optiro Pty Ltd (“Optiro”) to Chalice Gold Mines Limited and Northern Superior.Croteau hosts an inferred mineral resource of 11.6 Mt at 1.7 g/t Au for 640,000 ounces Au. Note that the technical and scientific information disclosed from neighboring properties does not apply to any other properties of the area.

SOURCE: Northern Superior Resources Inc.

View the original press release on ACCESS Newswire

CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, August 1, 2025 to report its second quarter 2025 financial results, and provide a corporate update.

A live webcast of the call will be available under “Events and Presentations” in the Investors section of the Moderna website.

• Webcast: https://investors.modernatx.com

The archived webcast will be available on Moderna’s website approximately two hours after the conference call and will be available for one year following the call.

About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire